Ido A - Search Results

1

Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study.

Tahata Y, Hikita H, Mochida S, Kawada N, Enomoto N, Ido A, Yoshiji H, Miki D, Hiasa Y, Takikawa Y, Sakamori R, Kurosaki M, Yatsuhashi H, Tateishi R, Ueno Y, Itoh Y, Yamashita T, Kanto T, Suda G, Nakamoto Y, Kato N, Asahina Y, Matsuura K, Terai S, Nakao K, Shimizu M, Takami T, Akuta N, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T. Tahata Y, et al. Among authors: ido a. J Gastroenterol. 2021 Jan;56(1):67-77. doi: 10.1007/s00535-020-01733-4. Epub 2020 Oct 1. J Gastroenterol. 2021. PMID: 33001338 Clinical Trial.

2

Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells.

Tsutsumi T, Ido A, Nakao K, Hamasaki K, Kato Y, Ohtsuru A, Nakata K, Tamaoki T, Nagataki S. Tsutsumi T, et al. Among authors: ido a. Gastroenterology. 1994 Aug;107(2):499-504. doi: 10.1016/0016-5085(94)90177-5. Gastroenterology. 1994. PMID: 7518784

3

Analysis of wild-type and e antigen-defective hepatitis B viruses during the course of a short-term corticosteroid therapy in chronic hepatitis B.

Daikoku M, Nakata K, Hamasaki K, Ido A, Nakao K, Kato Y, Koga M, Yano M, Nagataki S. Daikoku M, et al. Among authors: ido a. J Med Virol. 1995 Oct;47(2):184-8. doi: 10.1002/jmv.1890470213. J Med Virol. 1995. PMID: 8830124

4

Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C.

Sho Y, Fujisaki K, Sakashita H, Yamaguchi K, Tahara K, Kubozono O, Ido A, Tsubouchi H. Sho Y, et al. Among authors: ido a. J Gastroenterol. 2004 Dec;39(12):1202-4. doi: 10.1007/s00535-004-1472-0. J Gastroenterol. 2004. PMID: 15622486

5

Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan.

Uto H, Kurogi J, Takahama Y, Kusumoto K, Hayashi K, Ido A, Kohara M, Stuver SO, Moriuchi A, Hasegawa S, Oketani M, Tsubouchi H. Uto H, et al. Among authors: ido a. J Gastroenterol. 2007 Aug;42(8):673-80. doi: 10.1007/s00535-007-2078-0. Epub 2007 Aug 24. J Gastroenterol. 2007. PMID: 17701131

6

Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy.

Kodama M, Uto H, Numata M, Hori T, Murayama T, Sasaki F, Tsubouchi N, Ido A, Shimoda K, Tsubouchi H. Kodama M, et al. Among authors: ido a. J Gastroenterol. 2008;43(8):589-96. doi: 10.1007/s00535-008-2198-1. Epub 2008 Aug 17. J Gastroenterol. 2008. PMID: 18709480

7

Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.

Takahama Y, Uto H, Kanmura S, Oketani M, Ido A, Kusumoto K, Hasuike S, Nagata K, Hayashi K, Stuver S, Okayama A, Tsubouchi H. Takahama Y, et al. Among authors: ido a. J Gastroenterol. 2008;43(12):942-50. doi: 10.1007/s00535-008-2256-8. Epub 2008 Dec 24. J Gastroenterol. 2008. PMID: 19107338

8

Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study.

Uto H, Stuver SO, Hayashi K, Kumagai K, Sasaki F, Kanmura S, Numata M, Moriuchi A, Hasegawa S, Oketani M, Ido A, Kusumoto K, Hasuike S, Nagata K, Kohara M, Tsubouchi H. Uto H, et al. Among authors: ido a. Hepatology. 2009 Aug;50(2):393-9. doi: 10.1002/hep.23002. Hepatology. 2009. PMID: 19585614 Free PMC article.

9

Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C.

Nishida C, Uto H, Oketani M, Tokunaga K, Nosaki T, Fukumoto M, Oku M, Sogabe A, Moriuchi A, Ido A, Tsubouchi H. Nishida C, et al. Among authors: ido a. J Gastroenterol. 2010 Mar;45(3):326-34. doi: 10.1007/s00535-009-0149-0. Epub 2009 Nov 5. J Gastroenterol. 2010. PMID: 19890604

10

The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma.

Kanmura S, Uto H, Sato Y, Kumagai K, Sasaki F, Moriuchi A, Oketani M, Ido A, Nagata K, Hayashi K, Stuver SO, Tsubouchi H. Kanmura S, et al. Among authors: ido a. J Gastroenterol. 2010 Apr;45(4):459-67. doi: 10.1007/s00535-009-0160-5. Epub 2009 Dec 9. J Gastroenterol. 2010. PMID: 20012107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters